Human GCH1 knockout A549 cell lysate
Be the first to review this product! Submit a review
|
(0 Publication)
GCH1 KO cell lysate available now. KO validated by. Free of charge wild type control included. Knockout achieved by using CRISPR/Cas9, 1 bp insertion in exon1 and 2 bp deletion in exon1.
View Alternative Names
DYT 5, DYT14, DYT5a, Dystonia 14, GCH, GCH1_HUMAN, GTP CH 1, GTP cyclohydrolase 1, GTP cyclohydrolase 1 (dopa responsive dystonia), GTP cyclohydrolase I, GTP-CH-I, Guanosine 5' triphosphate cyclohydrolase I, HPABH4B
- Sanger seq
Unknown
Sanger Sequencing - Human GCH1 knockout A549 cell lysate (AB258878)
Allele-1 : 2 bp deletion in exon1
- Sanger seq
Unknown
Sanger Sequencing - Human GCH1 knockout A549 cell lysate (AB258878)
Allele-2 : 1 bp insertion in exon1
Product details
Knockout cell lysate achieved by CRISPR/Cas9.
REACH authorisation
Abcam has not and does not intend to apply for the REACH Authorisation of customers' uses of products that contain European Authorisation list (Annex XIV) substances.
It is the responsibility of our customers to check the necessity of application of REACH Authorisation, and any other relevant authorisations, for their intended uses.
Lysate preparation: Our lysates are made using RIPA buffer to which we add a protease inhibitor cocktail and phosphatase inhibitor cocktail (ratio: 300:100:10). This means that the protein of interest is denatured. If you require a native form of the protein please use the live cell version. Please refer to our lysis protocol for further details on how our lysates are prepared.
User storage instructions: Lyophilizate may be stored at 4°C. After reconstitution, store at -20°C for short-term storage or -80°C for long-term storage.
This product is subject to limited use licenses from The Broad Institute, ERS Genomics Limited and Sigma-Aldrich Co. LLC, and is developed with patented technology. For full details of the licenses and patents please refer to our limited use license and patent pages.
What's included?
Properties and storage information
Gene name
Gene editing type
Gene editing method
Knockout validation
Shipped at conditions
Appropriate short-term storage conditions
Appropriate long-term storage conditions
Quality control
STR analysis
CSF1PO, D13S317, D7S820, D5S818, TH01, D16S539, TPOX
Cell culture
Biosafety level
EU: 1 US: 1
Adherent/suspension
Adherent
Gender
Male
Complementary Products
Primary Antibodies
AB307507
Anti-GCH1 antibody [EPR27331-30]
BOND RX™ Validated|20ul selling size|RabMAb|Recombinant
![Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-GCH1 antibody [EPR27331-30] (AB307507)](https://content.abcam.com/products/images/gch1-antibody-epr27331-30-ab307507--immunohistochemistry-formalin-pfa-fixed-paraffin-embedded-sections-img405554.jpg)
- 0
- 0
![Western blot - Anti-TIMMDC1/C3orf1 antibody [EPR11807] (AB171978)](https://content.abcam.com/products/images/timmdc1-c3orf1-antibody-epr11807-ab171978--western-blot-img442100.jpg)
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com